An early integrated prognostic system for predicting relapse and guiding intervention post‐ <scp>CD19 CAR</scp> ‐T therapy in B‐cell acute lymphoblastic leukaemia
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Authors
- Yingwei Li (ORCID: https://orcid.org/0000-0002-1155-221X)
- Jiyu Wang (ORCID: https://orcid.org/0000-0003-1350-8770)
- Qing Zhang (ORCID: https://orcid.org/0000-0002-6592-6950)
- Jiamin Yao (ORCID: https://orcid.org/0000-0001-9753-2633)
- Furun An (ORCID: https://orcid.org/0000-0003-4089-3790)
- Zi Wang (ORCID: https://orcid.org/0000-0002-3953-0493)
- Wei Zhang (ORCID: https://orcid.org/0000-0001-7800-3189)
- Zhimin Zhai (ORCID: https://orcid.org/0000-0002-6685-6296)
- Weiwei Zhu (ORCID: https://orcid.org/0000-0002-3860-5481)
- Huiping Wang (ORCID: https://orcid.org/0000-0003-3733-7638)
- Qianshan Tao (ORCID: https://orcid.org/0000-0003-1269-5850)
- Lili Tao (ORCID: https://orcid.org/0000-0003-2647-7651)
- Caixian Xu
- Fan Wu
Institutions
- Anhui Medical University (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- British Journal of Haematology
- Published
- 2026-07-23
- DOI
- https://doi.org/10.1111/bjh.70715
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China